This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Eran Benjamin, PhD
Global Director, Analytical Development and Quality at PolyPeptide Group


Eran J. Benjamin received his doctorate in Organic Chemistry with Prof. Mati Fridkin at the Weizmann Institute of Science and is currently the Global Director of Quality Control and Analytical Development at the PolyPeptide Group, based in Torrance CA. Prior to joining Polypeptide, Eran was a Principal Research Sceintist at Eli Lilly and Company in the development and commercialization of Insulins and Peptide-based therapeutics and was the Director of characterization science and small molecule analytical development.

Agenda Sessions

  • Tailoring Control Strategies to Meet Specific Peptide Drug Substance Complexity, Customer Needs and Regulatory Requirements